Product Details
1/EA
$ *.**
In StockAdditional Information
| Product Name | Remicade 100 mg SDV |
| Active Ingredient | Infliximab |
| Mechanism of Action | TNF-a inhibitor that neutralizes tumor necrosis factor-alpha, reducing inflammation in autoimmune diseases |
| Strength | 100 mg per vial |
| Dosage Form | Lyophilized Powder for Injection |
| Route of Administration | Intravenous Infusion |
| Common Side Effects | Infusion reactions, headache, respiratory infections, fatigue, nausea |
| Serious Adverse Effects | Increased risk of infections, tuberculosis reactivation, malignancies, hepatotoxicity, demyelinating diseases |
| Preparation for Administration | Reconstituted with sterile water and diluted in 0.9% sodium chloride for intravenous infusion |
| Packaging | Single-dose vial |
| Storage Conditions | Refrigerate at 2°C to 8°C (36°F to 46°F); do not freeze or shake |
| Indications | Rheumatoid arthritis, Crohn’s disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis |
Description
Remicade 100 mg SDV is a monoclonal antibody-based biological agent containing infliximab. It is classified as a tumor necrosis factor-alpha (TNF-a) inhibitor, designed to neutralize the activity of TNF-a, a pro-inflammatory cytokine implicated in autoimmune disorders. By blocking TNF-a, the drug reduces inflammation and modulates immune system activity, providing therapeutic effects in chronic inflammatory conditions.
This medication is indicated for the treatment of autoimmune diseases, including rheumatoid arthritis, Crohn’s disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. It is often used in patients who have had an inadequate response to conventional therapies, such as disease-modifying antirheumatic drugs (DMARDs) or corticosteroids.
Common adverse effects include infusion-related reactions, respiratory infections, headache, and fatigue. Serious adverse events may include an increased risk of severe infections, tuberculosis reactivation, malignancies, hepatotoxicity, and demyelinating diseases. Patients should undergo tuberculosis screening and other relevant tests before initiation.
Frequently Asked Questions (FAQs)
The cost of REMICADE 100 MG SDV is $$0.00
REMICADE 100 MG SDV is manufactured by Janssen.
You can purchase REMICADE 100 MG SDV on our website at https://supplies.pipelinemedical.com/product/detail/remicade-100-mg-sdv-666303